Biocryst Pharmaceuticals (BCRX) Tax Rate (2021 - 2026)

Biocryst Pharmaceuticals has reported Tax Rate for 6 years, with the latest figure at 0.14% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate fell 9592.0% year-over-year to 0.14%; the trailing twelve-month figure through Mar 2026 stood at 0.84% (up 363.0% YoY), and the FY2025 full-year result was 1.32%, up 354.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.14%, down from 0.88% in the prior quarter.
• The five-year high for Tax Rate was 95.78% in Q1 2025, with the low at 6.34% in Q3 2025.
• Historically, Tax Rate has averaged 5.61% across 5 years, with a median of 0.99% in 2023.
• Annual changes were most pronounced in 2025 — Tax Rate surged 9682 bps — and 2026, when it sank 9592 bps.
• Biocryst Pharmaceuticals' Tax Rate stood at 0.11% in 2022, then surged by 2230 bps to 2.27% in 2023, then tumbled by 237 bps to 3.09% in 2024, then jumped by 128 bps to 0.88% in 2025, then tumbled by 116 bps to 0.14% in 2026.
• The last three Tax Rate figures came in at 0.14% (Q1 2026), 0.88% (Q4 2025), and 6.34% (Q3 2025), per Business Quant data.